ID

31752

Description

A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00912899

Link

https://clinicaltrials.gov/show/NCT00912899

Keywords

Versions (1)
  1. 9/25/18 9/25/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 25, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Refractory Multiple Myeloma NCT00912899

English

Eligibility Refractory Multiple Myeloma NCT00912899

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
advanced multiple myeloma.
Description

Multiple Myeloma Advanced

Data type

boolean

Alias
UMLS CUI [1,1]
C0026764
UMLS CUI [1,2]
C0205179
progression after ≥ 2 lines of prior therapy, including at least one steroid, one immunomodulatory agent (imid), one alkylator, and bortezomib (velcade®).
Description

Disease Progression | Status post Prior Therapy Course Quantity | Steroids Quantity | Biological Response Modifiers Quantity | Alkylating Agents Quantity | bortezomib | Velcade

Data type

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C1514463
UMLS CUI [2,3]
C0750729
UMLS CUI [2,4]
C1265611
UMLS CUI [3,1]
C0038317
UMLS CUI [3,2]
C1265611
UMLS CUI [4,1]
C0005525
UMLS CUI [4,2]
C1265611
UMLS CUI [5,1]
C0002073
UMLS CUI [5,2]
C1265611
UMLS CUI [6]
C1176309
UMLS CUI [7]
C1174739
ecog performance status of either 0 or 1.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior chemotherapy with antimicrotubule agents
Description

Prior Chemotherapy | Antimitotic Agents

Data type

boolean

Alias
UMLS CUI [1]
C1514457
UMLS CUI [2]
C0003379
metastasis involving the brain or spinal cord
Description

Metastatic malignant neoplasm to brain | Secondary malignant neoplasm of spinal cord

Data type

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C0347016
clinically significant lung or heart disease
Description

Lung disease | Heart Disease

Data type

boolean

Alias
UMLS CUI [1]
C0024115
UMLS CUI [2]
C0018799
abnormal electrocardiogram
Description

Electrocardiogram abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0522055
please note that there are additional inclusion and exclusion criteria. the study center will determine if you meet all of the criteria.
Description

Eligibility Criteria Additional

Data type

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1524062
site personnel will explain the trial in detail and answer any question you may have if you do qualify for the study. you can then decide whether or not you wish to participate. if you do not qualify for the trial, site personnel will explain the reasons.
Description

Study Subject Participation Status | Counseling Research Personnel

Data type

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C0010210
UMLS CUI [2,2]
C0035173
Back to the top of the page

Similar models

Eligibility Refractory Multiple Myeloma NCT00912899

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Multiple Myeloma Advanced
Item
advanced multiple myeloma.
boolean
C0026764 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
Disease Progression | Status post Prior Therapy Course Quantity | Steroids Quantity | Biological Response Modifiers Quantity | Alkylating Agents Quantity | bortezomib | Velcade
Item
progression after ≥ 2 lines of prior therapy, including at least one steroid, one immunomodulatory agent (imid), one alkylator, and bortezomib (velcade®).
boolean
C0242656 (UMLS CUI [1])
C0231290 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
C0750729 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
C0038317 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0005525 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
C0002073 (UMLS CUI [5,1])
C1265611 (UMLS CUI [5,2])
C1176309 (UMLS CUI [6])
C1174739 (UMLS CUI [7])
ECOG performance status
Item
ecog performance status of either 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Chemotherapy | Antimitotic Agents
Item
prior chemotherapy with antimicrotubule agents
boolean
C1514457 (UMLS CUI [1])
C0003379 (UMLS CUI [2])
Metastatic malignant neoplasm to brain | Secondary malignant neoplasm of spinal cord
Item
metastasis involving the brain or spinal cord
boolean
C0220650 (UMLS CUI [1])
C0347016 (UMLS CUI [2])
Lung disease | Heart Disease
Item
clinically significant lung or heart disease
boolean
C0024115 (UMLS CUI [1])
C0018799 (UMLS CUI [2])
Electrocardiogram abnormal
Item
abnormal electrocardiogram
boolean
C0522055 (UMLS CUI [1])
Eligibility Criteria Additional
Item
please note that there are additional inclusion and exclusion criteria. the study center will determine if you meet all of the criteria.
boolean
C1516637 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])
Study Subject Participation Status | Counseling Research Personnel
Item
site personnel will explain the trial in detail and answer any question you may have if you do qualify for the study. you can then decide whether or not you wish to participate. if you do not qualify for the trial, site personnel will explain the reasons.
boolean
C2348568 (UMLS CUI [1])
C0010210 (UMLS CUI [2,1])
C0035173 (UMLS CUI [2,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial